<DOC>
	<DOCNO>NCT00005872</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness nitrocamptothecin treat patient recurrent non-small cell lung cancer .</brief_summary>
	<brief_title>Nitrocamptothecin Treating Patients With Recurrent Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate , time progression overall survival patient recurrent non-small cell lung cancer treat nitrocamptothecin . II . Assess toxicity pharmacokinetics regimen patient . OUTLINE : Patients receive oral nitrocamptothecin daily day 1-5 . Treatment continue weekly absence disease progression unacceptable toxicity . Patients follow survival . PROJECTED ACCRUAL : A total 20-55 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Rubitecan</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm recurrent nonsmall cell lung cancer No one prior chemotherapy treatment Bidimensionally measurable disease No prior radiotherapy target lesion OR Progression since prior radiotherapy PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 2.0 mg/dL ALT/AST great 3 time upper limit normal ( ULN ) ( great 5 time ULN case liver metastasis ) Renal : Creatinine great 2.0 mg/dL OR Creatinine clearance least 50 mL/min Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No uncontrolled serious medical psychiatric illness PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics At least 3 week since prior chemotherapy recover No prior camptothecin Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics At least 3 week since prior radiotherapy recover Surgery : At least 2 week since prior major surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2001</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
</DOC>